Notification of major interest in shares

RNS Number : 2069B
ConvaTec Group PLC
31 March 2017
 

 

 

TR1 NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

CONVATEC GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:
iii

NORDIC CAPITAL VI LIMITED

NORDIC CAPITAL VII LIMITED

 

4. Full name of shareholder(s)
 (if different from 3.):iv

CIDRON HEALTHCARE TOPCO LIMITED

CIDRON HEALTHCARE CO-INVEST LIMITED

CIDRON HEALTHCARE CO-INVEST II LIMITED

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

 

31 MARCH 2017

6. Date on which issuer notified:

31 MARCH 2017

7. Threshold(s) that is/are crossed or
reached:
vi, vii

Below 17%

         
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY SHARES OF £0.10 EACH

849,181,983

849,181,983

 

N/A

314,158,828

N/A

16.10%

GB00BD3VFW73

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

N/A

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

314,158,828

 

16.10%

                                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI.

 

Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII.

 

Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A

 


13. Additional information:

This disclosure has been calculated based on issued share capital of 1,951,472,651 shares as disclosed by ConvaTec Group Plc in its Annual Report and Accounts for the year ended 31 December 2016

14. Contact name:

LYNDA ELLIOTT

15. Contact telephone number:

+ 44 1534 605105

     

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLWGURCWUPMGPG
UK 100

Latest directors dealings